Navigation Links
Syndax Pharmaceuticals Elects Arlene Morris to Board of Directors
Date:6/8/2011

WALTHAM, Mass., June 8, 2011 /PRNewswire/ -- Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced that Arlene Morris has been elected to the board of directors.  Ms. Morris most recently was the chief executive officer and a member of the board of directors of Affymax, Inc., a biopharmaceutical company that was spun out of GlaxoSmithKline (GSK) in 2001 to develop a pipeline of synthetic peptide-based drug candidates for the treatment of anemia in dialysis patients.  

"Arlene is bringing to Syndax extensive biotechnology and pharmaceutical experience in general management, marketing, sales, business development and strategic marketing," said Dennis Podlesak, chairman of the Syndax board of directors.  "With entinostat entering a phase 3 program this is a great time for Arlene to leverage her extensive experience and provide guidance as we are moving in to the final stages of clinical development."

"I am excited to join the board as Syndax moves into pivotal trials with entinostat in women with metastatic breast cancer, an area where resistance poses an ongoing problem," said Ms. Morris.  "Syndax provides a great opportunity for me to contribute to the direction of a company with a promising oncology pipeline aimed at improving survival outcomes with a non-chemotherapy option."

During her eight years as president and CEO at Affymax, Ms. Morris led the company through the development of peginesatide (Hematide™), a strategic collaboration with Takeda and an Initial Public Offering.  Prior to Affymax Ms. Morris was the president and CEO of Clearview Projects, an advisory firm which counsels biopharmaceutical and biotechnology companies on strategic transactions. Before that she was the senior vice president, business development at Coulter, a biotechnology company focused on immunotherapeutic approaches to cancer, autoimmune and infectious diseases, where she completed numerous transactio
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
2. Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
3. Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat
4. Syndax Pharmaceuticals Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients
5. Syndax Pharmaceuticals Entinostat in Combination Shows Activity in Breast Cancer
6. Syndax Pharmaceuticals to Present at Biotech Showcase 2011
7. Syndax Announces Publication of Entinostat NSCLC Data in Cancer Research
8. Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer
9. Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting
10. Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... TIJUANA, Mexico , Dec. 24, 2014 /PRNewswire/ ... treatment of its first patient in its study ... to the American Stroke Association, ischemic strokes account ... continues to enroll qualified patients in the study, ... Intravenous Administration of Allogeneic Mesenchymal Stem Cells and ...
(Date:12/24/2014)... 24, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that on December 24, 2014 it closed ... The Company raised approximately $2.3 million in gross ... the net proceeds from the offering to fund ...
(Date:12/24/2014)... , December 24, 2014 ... at an average rate of 8.1%. The US has ... knee and spine surgeries are the common orthopedic procedures ... have a lower penetration. Increased number of product recalls ... Non-metallic orthopedic devices have gained popularity in the industry ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
(Date:12/26/2014)... (DaWei Induction Heating Co.) is a comprehensive high-tech business ... of a series of induction heating equipment. Today, the ... induction brazing equipments . , According to a ... refers to the joining of two or more components ... says that there are fundamental differences in the two ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 The ... Analysis to 2023” focuses on the current treatment ... in the colorectal cancer market. Stivarga is a ... colon or rectal cancer. Boehringer Ingelheim is developing ... the treatment of refractory CRC in the US, ...
(Date:12/25/2014)... 2014 Recently, Dylan Queen, a famous ... released its collection of discounted prom dresses, most of ... senior spokesman of the company, the promotion is valid ... is to expand the UK market. , The prom ... colors, lengths, and styles: A-line strapless, empire strapless chiffon, ...
(Date:12/25/2014)... When head lice hits a home or school, parents and ... of it while keeping it from taking over the house ... solution right in their neighborhood: Lice Troopers . Expanding ... spectrum head lice screening and treatment services to families and ... Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , The ...
(Date:12/25/2014)... (HealthDay News) -- Among early stage breast cancer patients ... of one percent will eventually develop leukemia as a ... The finding comes from a review of more than ... and it suggests that the risk for developing treatment-related ... previously thought. "The frequency of bone marrow cancers ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... analysis has found that a considerable proportion of ... benefit from palliative radiation therapy (radiotherapy) despite spending ... early online in CANCER , a peer-reviewed ... indicates that greater efforts are needed to tailor ...
... Microscope depicts on its screen the few nanometer thick ... crisscrossing the surface on which they are deposited. The ... that they can self assemble into complex ribbon-like twisted ... of Fribourg have teamed up to take Atomic Force ...
... ... selected DOMA Technologies to provide Medical Coding Services to select Northwest ... using their iCodeRx SaaS application and ensure that coding services meet ... and assemble medical record data and assign diagnoses and procedure codes ...
... legs seen in many patients under 55: study , ... may be much more common in younger American adults and ... The disease causes a narrowing in blood vessels that carry ... to symptoms that include pain and cramping in the legs ...
... ... robust new website that highlights the practice’s state-of-the-art treatments and gentle, personalized approach. Drs. Bradley ... and engaging look at all the practice has to offer. , ... San Diego, CA (Vocus) April 10, 2010 -- Two ...
... ... equivalent of 10,000 laser targeted marketing postcards to all of your patient,s friends for ... ... the easiest chiropractic marketing can be done right now in the office for ...
Cached Medicine News:Health News:Terminal cancer patients do not receive appropriate radiation therapy 2Health News:The assembly of protein strands into fibrils 2Health News:Army Awards Remote Medical Coding Contract to DOMA Technologies 2Health News:Severe Arterial Disease Found in Younger Adults 2Health News:San Diego Cosmetic Dentists Launch New Website and Rejuvenate Online Image 2Health News:San Diego Cosmetic Dentists Launch New Website and Rejuvenate Online Image 3Health News:Chiropractic Traffic CEO Matt Prados Releases the Easiest and Fastest Free Chiropractic Marketing Method Known to Man 2
... FlexSure HP is a visually read, qualitative ... to H. pylori, a bacterium that grows ... peptic ulcer disease and some gastric cancers. ... whole blood or serum samples, provides the ...
Rapid Infectious Mononucleosis Heterophile Antibody (IgM) Test...
... Whole Blood Test is a rapid ... of IgM antibodies specific to infectious ... This test kit can be used ... IM in patients with clinical symptoms ...
... available point-of-care diagnostic test that can reliably ... A and B. The test uses a ... that assists viral replication by promoting the ... The ZstatFlu substrate is labeled with a ...
Medicine Products: